NUBIYOTA LLC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are ALLERGY THERAPEUTICS UK LTD, ADVANCED BIOADJUVANTS LLC and GENETIC IMMUNITY LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 2 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Chile | 1 | |
#7 | China | 1 | |
#8 | Colombia | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Peru | 1 | |
#12 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Allen-Vercoe Emma | 12 |
#2 | Mashiach Nissim | 2 |
#3 | Langer Shawn | 2 |
#4 | Mcdonald Julie | 1 |
#5 | Allen Vercoe Emma | 1 |
Publication | Filing date | Title |
---|---|---|
CA3087695A1 | Compositions comprising co-selected microbiota and methods for use thereof | |
WO2017137848A1 | Systems and methods for characterizing compositions comprising fecal-derived bacterial populations |